Han G P, Xu Y Y, Li Z H, Meng C, Zhu H J, Yang K L, Zhou L Q, Li X S
Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China.
Department of Urology, Beijing Jiangong Hospital, Beijing 100054, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):762-765. doi: 10.19723/j.issn.1671-167X.2022.04.029.
Ureteral stenosis is a comparatively rare complication following hematopoietic stem cell transplantation (HSCT). The etiology is still unclear and most believe that this may be due to the reactivation of BK virus in a state of immunodeficiency. In the later stages of ureteral stenosis with scarring, invasive interventions must be taken to relieve the hydronephrosis. Common treatments, such as D-J stent placement and permanent nephrostomy may not only entail the risk of infection, but also seriously affect the quality of life. Few cases of surgical intervention have been reported. In this article, a 25-year-old female was admitted to Peking University First Hospital suffering from recurrent flank pain. Seven years before, she developed hemorrhagic cystitis and bilateral urethritis 40 days after allogeneic HSCT. After continuous bladder irrigation and antiviral therapy, the left-sided hydronephrosis gradually alleviated while the right-sided one did not improve. D-J stents were used for urine drainage for 7 years before percuta-neous nephrostomy. Preoperative antegrade pyelography revealed significant hydronephrosis in the right kidney with long stricture of proximal-middle ureter. After comprehensive decision, she underwent ileal ureter replacement. The operation was successful. The segmental lesion was dissected and the scar tissue was removed. A 25 cm intestinal tube was isolated to connect the pelvis and bladder. An anti-reflux nipple was created at the distal end of ileal ureter to prevent the potential infection. The blood loss was minimal. After surgery, the drainage tube was removed in 2 weeks, the nephrostomy tube and the D-J stent was removed in 3 months. Follow-up mainly included clinical assessment, serologic testing, renal ultrasonography, blood gas analysis and radiological examination. During the follow-up of 6 years, she was symptom-free and no postoperative complications occurred. The serum creatinine level was stable. No hydronephrosis was observed under ultrasonography. Obvious peristaltic waves and ureteral jets of the ileal ureter was confirmed on cine magnetic resonance urography. To sum up, ureteral stenosis after HSCT is relatively rare. Obstruction caused by scarring is usually irreversible and surgical intervention should be designed according to the location and length of the lesion. Ileal ureter replacement can be a safe, feasible and effective method to solve this kind of complex stricture.
输尿管狭窄是造血干细胞移植(HSCT)后一种相对罕见的并发症。其病因尚不清楚,多数人认为这可能是由于免疫缺陷状态下BK病毒重新激活所致。在输尿管狭窄伴有瘢痕形成的后期,必须采取侵入性干预措施来缓解肾积水。常见的治疗方法,如放置D-J支架和永久性肾造瘘术,不仅有感染风险,还会严重影响生活质量。手术干预的病例报道较少。本文中,一名25岁女性因反复侧腹痛入住北京大学第一医院。7年前,她在异基因HSCT后40天出现出血性膀胱炎和双侧尿道炎。经过持续膀胱冲洗和抗病毒治疗,左侧肾积水逐渐缓解,而右侧肾积水没有改善。在进行经皮肾造瘘术之前,使用D-J支架引流尿液7年。术前顺行肾盂造影显示右肾严重肾积水,输尿管近中段长段狭窄。综合评估后,她接受了回肠代输尿管术。手术成功。切除了节段性病变并清除了瘢痕组织。截取一段25厘米长的肠管连接肾盂和膀胱。在回肠代输尿管远端制作了一个抗反流乳头以防止潜在感染。术中出血极少。术后2周拔除引流管,3个月拔除肾造瘘管和D-J支架。随访主要包括临床评估、血清学检测、肾脏超声检查、血气分析和影像学检查。在6年的随访期间,她无症状,未发生术后并发症。血清肌酐水平稳定。超声检查未发现肾积水。在电影磁共振尿路造影上证实回肠代输尿管有明显的蠕动波和输尿管喷射。综上所述,HSCT后输尿管狭窄相对罕见。瘢痕形成导致的梗阻通常是不可逆的,应根据病变的部位和长度设计手术干预方案。回肠代输尿管术可以是解决这类复杂狭窄的一种安全、可行且有效的方法。